We are live on ! Find out more
BFEC

Benjamin F. Edwards & Company Portfolio holdings

AUM $5.69B
1-Year Est. Return 15.37%
This Fund
S&P 500
This Quarter Est. Return
-11.91%
1 Year Est. Return
+15.37%
3 Year Est. Return
+19.73%
5 Year Est. Return
+83.07%
10 Year Est. Return
+162.03%
AUM
$2.07B
AUM Growth
-$171M
Cap. Flow
+$134M
Cap. Flow %
6.49%
Top 10 Hldgs %
18.9%
Holding
1,939
New
161
Increased
675
Reduced
422
Closed
109
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRNX icon
1576
Crinetics Pharmaceuticals
CRNX
$9B
$4K ﹤0.01%
200
CWH icon
1577
Camping World
CWH
$412M
$4K ﹤0.01%
200
CWK icon
1578
Cushman & Wakefield Ltd
CWK
$3.34B
$4K ﹤0.01%
246
DELL icon
1579
Dell
DELL
$303B
$4K ﹤0.01%
79
DOX icon
1580
Amdocs
DOX
$6.61B
$4K ﹤0.01%
54
EXPO icon
1581
Exponent
EXPO
$3.38B
$4K ﹤0.01%
47
FWRD icon
1582
Forward Air
FWRD
$601M
$4K ﹤0.01%
46
HMN icon
1583
Horace Mann Educators
HMN
$2.08B
$4K ﹤0.01%
99
IONS icon
1584
Ionis Pharmaceuticals
IONS
$10.1B
$4K ﹤0.01%
119
IX icon
1585
ORIX
IX
$42.5B
$4K ﹤0.01%
+210
New +$3.82K
JETS icon
1586
US Global Jets ETF
JETS
$792M
$4K ﹤0.01%
225
-300
-57% -$5.91K
LBRDK
1587
DELISTED
Liberty Broadband Class C
LBRDK
$4K ﹤0.01%
34
LH icon
1588
Labcorp
LH
$27.2B
$4K ﹤0.01%
21
-7
-25% -$1.49K
LW icon
1589
Lamb Weston
LW
$7.58B
$4K ﹤0.01%
50
MAGA icon
1590
Truth Social America First ETF
MAGA
$31.6M
$4K ﹤0.01%
100
MYPS icon
1591
PLAYSTUDIOS Inc
MYPS
$60.2M
$4K ﹤0.01%
1,000
NBIX icon
1592
Neurocrine Biosciences
NBIX
$15.8B
$4K ﹤0.01%
+46
New +$4.25K
RCL icon
1593
Royal Caribbean
RCL
$76.7B
$4K ﹤0.01%
125
+8
+7% +$498
RYAN icon
1594
Ryan Specialty Holdings
RYAN
$11.2B
$4K ﹤0.01%
114
FLNA
1595
Filana Therapeutics
FLNA
$44.9M
$4K ﹤0.01%
153
SKX
1596
DELISTED
Skechers
SKX
$4K ﹤0.01%
100
TGTX icon
1597
TG Therapeutics
TGTX
$8.43B
$4K ﹤0.01%
900
-1,000
-53% -$6.24K
THW
1598
abrdn World Healthcare Fund
THW
$567M
$4K ﹤0.01%
286
+6
+2% +$92
TLYS icon
1599
Tilly's
TLYS
$118M
$4K ﹤0.01%
500
USPH icon
1600
US Physical Therapy
USPH
$1.2B
$4K ﹤0.01%
37

Similar funds

Benjamin F. Edwards & Company's Q2 2022 Portfolio in Review

As of Q2 2022, Benjamin F. Edwards & Company held 1,939 positions worth $2.07B, down 7.6% from $2.24B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Benjamin F. Edwards & Company deployed $134M of net new capital in Q2 2022, opening 161 new positions and adding to 675 existing holdings. Its largest new stake was iShares BB Rated Corporate Bond ETF: 595,236 shares worth $26.3M.

By sector, the portfolio is most concentrated in Miscellaneous at 63% of assets, up from 61% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was iShares iBonds Dec 2025 Term Treasury ETF, an estimated $13.3M trimmed.

  • Benjamin F. Edwards & Company's largest Q2 2022 buy was iShares BB Rated Corporate Bond ETF: 595,236 shares worth $26.3M.
  • Benjamin F. Edwards & Company added most to First Trust Nasdaq Food & Beverage ETF in Q2 2022, an estimated $8.98M increase.
  • Benjamin F. Edwards & Company's biggest Q2 2022 reduction was iShares iBonds Dec 2025 Term Treasury ETF, cutting an estimated $13.3M.
  • Benjamin F. Edwards & Company fully exited iShares MSCI United Kingdom Small-Cap ETF in Q2 2022, selling an estimated $3.4M.
  • Benjamin F. Edwards & Company's ten largest holdings make up 19% of its $2.07B portfolio in Q2 2022.
  • Benjamin F. Edwards & Company opened 161 new positions and closed 109 in Q2 2022.
  • Benjamin F. Edwards & Company's portfolio value fell 7.6% quarter-over-quarter to $2.07B.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2022, filed 12 Aug 2022.